A vision transformer‐based deep transfer learning nomogram for predicting lymph node metastasis in lung adenocarcinoma
Background Lymph node metastasis (LNM) plays a crucial role in the management of lung cancer; however, the ability of chest computed tomography (CT) imaging to detect LNM status is limited. Purpose This study aimed to develop and validate a vision transformer‐based deep transfer learning nomogram fo...
Gespeichert in:
Veröffentlicht in: | Medical physics (Lancaster) 2025-01, Vol.52 (1), p.375-387 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Lymph node metastasis (LNM) plays a crucial role in the management of lung cancer; however, the ability of chest computed tomography (CT) imaging to detect LNM status is limited.
Purpose
This study aimed to develop and validate a vision transformer‐based deep transfer learning nomogram for predicting LNM in lung adenocarcinoma patients using preoperative unenhanced chest CT imaging.
Methods
This study included 528 patients with lung adenocarcinoma who were randomly divided into training and validation cohorts at a 7:3 ratio. The pretrained vision transformer (ViT) was utilized to extract deep transfer learning (DTL) feature, and logistic regression was employed to construct a ViT‐based DTL model. Subsequently, the model was compared with six classical convolutional neural network (CNN) models. Finally, the ViT‐based DTL signature was combined with independent clinical predictors to construct a ViT‐based deep transfer learning nomogram (DTLN).
Results
The ViT‐based DTL model showed good performance, with an area under the curve (AUC) of 0.821 (95% CI, 0.775–0.867) in the training cohort and 0.825 (95% CI, 0.758–0.891) in the validation cohort. The ViT‐based DTL model demonstrated comparable performance to classical CNN models in predicting LNM, and the ViT‐based DTL signature was then used to construct ViT‐based DTLN with independent clinical predictors such as tumor maximum diameter, location, and density. The DTLN achieved the best predictive performance, with AUCs of 0.865 (95% CI, 0.827–0.903) and 0.894 (95% CI, 0845–0942), respectively, surpassing both the clinical factor model and the ViT‐based DTL model (p |
---|---|
ISSN: | 0094-2405 2473-4209 2473-4209 |
DOI: | 10.1002/mp.17414 |